Leveraging New Systems Biology Tools & High Throughput Screening in Microbiome Research: From the Mechanism of Action to a Story of Success
Time: 2:10 pm
day: Conference Day One
Details:
- Understanding the issue: target conditions as starting point in microbiome research
- Employing systems biology and high throughput pre-clinical models predictive of clinical outcomes
- Outlining ABB C1 case: from in vitro screening to clinical validation of a powerful synergy as well as DAO case: from an unmet medical need to a product range with defined MoA and tailored indications
